Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

SAR-444836

Alternative Names: SAR-444836, SAR 444836, SAR444836
Latest Update: 2024-01-25
Latest Update Note: Clinical Trial Update

Product Description

Sanofi is developing SAR-444836 as a treatment for Phenylketonuria. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT05972629)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for SAR-444836

Countries in Clinic: Turkey

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Phenylketonurias

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
DFI17545

P2

Recruiting

Phenylketonurias

2027-07-31

Recent News Events

Date

Type

Title

10/27/2023

News Article

 MediciNova's Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of Phenylketonuria

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions